Why Cocaine is Used for Epistaxis
Cocaine is used to treat epistaxis because it uniquely combines potent topical vasoconstriction with local anesthesia in a single agent, making it effective for controlling nasal bleeding while providing pain relief during procedures like cautery or nasal packing. 1
Dual Mechanism of Action
Cocaine stands apart from other topical agents because it provides two critical properties simultaneously:
- Vasoconstriction: Constricts nasal blood vessels to reduce bleeding
- Local anesthesia: Numbs the nasal mucosa to allow painless intervention
This dual action makes cocaine particularly valuable when you need to both stop bleeding AND perform a painful procedure like chemical or electrical cautery 1.
Clinical Application According to Guidelines
The 2020 American Academy of Otolaryngology guidelines explicitly list cocaine among appropriate topical vasoconstrictors for epistaxis management 1. When you identify an anterior bleeding site, the guideline recommends:
- Apply topical vasoconstricting agents (oxymetazoline, phenylephrine, epinephrine, or cocaine)
- Perform nasal cautery if needed
- Use moisturizing agents after bleeding stops
The guideline intentionally does not specify a preferred vasoconstrictor, acknowledging that combinations of methods are often used and there is limited evidence comparing these options directly 1.
Practical Considerations
When Cocaine Makes Sense:
- Patient requires nasal cautery (chemical or electrical)
- Need simultaneous anesthesia and vasoconstriction
- Preparing for nasal packing procedures
- Performing nasal endoscopy to locate bleeding source
Important Caveats:
Cardiovascular toxicity is unpredictable and can occur even with topical application 2. A case report documented acute hypertension, tachycardia, and dysphoria immediately after 4% topical cocaine pledgets, requiring labetalol for reversal 2.
Avoid cocaine in patients with:
- Known cardiac disease 3
- Hypertension
- Ischemic heart disease 4
- Increased intraocular pressure (narrow angle glaucoma) 4
Alternative Agents Are Equally Effective
Recent high-quality evidence challenges cocaine's necessity:
- A 2024 randomized trial found no statistical difference between 4% cocaine and 0.05% xylometazoline in preventing epistaxis during nasotracheal intubation (60.4% vs 69.4% bleeding rates, p=0.41) 5
- A 2025 crossover trial comparing cocaine to lidocaine/xylometazoline for nasal intubation showed no clinically important pain differences 6
These studies suggest that separate vasoconstrictor + anesthetic combinations work just as well as cocaine without the cardiac risk profile 5, 6.
Recommended Approach
For most epistaxis cases, start with safer alternatives:
- First-line: Oxymetazoline or phenylephrine (65-75% resolution rate) 1
- If cautery needed: Add topical lidocaine for anesthesia 1
- Reserve cocaine for: Cases where you specifically need the combined effect and patient has no cardiac contraindications
Maximum safe dose: 200-300 mg total for most adult procedures 7. The toxic dose is unpredictable, and serum levels vary significantly with application method 8.
Common Pitfall
Do not assume cocaine is superior simply because it's traditional. A 2006 literature review concluded that "the relative benefit of using cocaine in relation to other topical analgesics and vasoconstrictors in surgery remains unproven" 3. The risk/benefit analysis favors non-cocaine alternatives in outpatient settings 3.
Bottom Line for Practice
Cocaine works for epistaxis through vasoconstriction and anesthesia, but modern evidence supports using separate, safer agents (topical decongestant + local anesthetic) that achieve equivalent outcomes without unpredictable cardiovascular toxicity 6, 2, 3, 5. Reserve cocaine for specific situations where its dual action provides clear procedural advantage and cardiac risk is acceptable.